Radiotherapy Patient Positioning Accessories Market will rise at 5.1% CAGR over the forecast period from 2022 to 2028

Estimated to exceed the revenues of US$ 588.8 million in 2022, the global market for radiotherapy patient positioning accessories is projected to witness a moderate 4.3% annual growth in revenue, over that in 2021. According to a recent research study of Future Market Insights (FMI), nearly 1/5th of the overall installed base of radiotherapy patient positioning accessories is accounted by couch tops and overlays, followed by immobilization systems.

More than 40% of the total adoption of radiotherapy patient positioning accessories is registered by hospitals at a global level, as indicated by FMI’s report. A higher rate of demand for radiotherapy patient positioning accessories is likely to be recorded by cancer research institutes and radiation therapy/proton therapy centers, in the forthcoming years.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9325

Government Support Pivotal in Accelerating Installation of Radiotherapy Patient Positioning Accessories

North America and Europe currently hold a combined revenue share of over 60% in the global radiotherapy patient positioning accessories market. Remarkable increase in the rate of early cancer diagnosis is leading to hike in the adoption of radiotherapy, more prominently in developed countries such as the US, UK, and Germany among others. Moreover, the study opines that the increasing awareness about multiple types of cancers, further backed by favorable government initiatives regarding cancer diagnosis and treatment, will be one of the strongest factors pushing penetration of radiotherapy patient positioning accessories within developed regional markets.

On the other side, governments of several developing economies are also extending support and investments in the cancer diagnosis and treatment space, particularly through screening camps – which is boosting the diagnosis rates of cancer. This according to the report is majorly responsible for promising growth in the installed base of radiotherapy systems and patient positioning accessories. According to FMI’s analysis, the flourishing medical tourism sector is also registering significant contribution to the thriving demand for radiotherapy patient positioning accessories in emerging economies.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9325

Strategic Efforts in Stronger Distribution Network Gathering Momentum among Manufacturers

Some of the key players actively competing in the radiotherapy patient positioning accessories market include Bionix Radiation Therapy, CDR Systems, CIVCO Radiation, Orfit Industries N.V., IZI Medical Products, Klarity Medical Products, Qfix, Elekta AB, and Eckert & Ziegler BEBIG, among others. Several leading manufactures are focused on the development and approval of new products. CIVCO Radiotherapy announced the FDA clearance and CE mark for their Solstice SRS Immobilisation System, in the H2 2021.

Strong distribution partnerships tend to result in effective product reach across the value chain and thereby supports the business growth. While the growing trend of strategic distribution partnerships between peer companies operating in the radiotherapy patient positioning accessories market is translating into improved product outreach, FMI’s analysis suggests that collaborative activities in terms of distribution of radiotherapy patient positioning accessories will particularly benefit smaller players in the market. Recently, POLL Medical entered the partnership with CIVCO for the global distribution of CE-marked GrayDuck Stents.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-9325

Radiotherapy Patient Positioning Accessories Market by Category

By Product Type

  • Couch Tops & Overlays
  • Immobilization System
  • Head Rest
  • Cushions
  • Spacers & Wedges
  • Arm & Wrist Supports
  • Thermoplastic Masks & Sheets
  • Locating & Indexing Bar
  • Bite Positioner
  • Markers

By End User

  • Hospitals
  • Radiation/Proton Therapy Centers
  • Cancer Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Electronic Stethoscope Market is expected to create an incremental opportunity worth US$ 170.9 Mn between 2022 and 2029

Up from nearly half a million units sold in 2018, the global sales of electronic stethoscopes will observe a robust 7.2% growth in 2022. The electronic stethoscopes market is expected to create an incremental opportunity worth US$ 170.9 Mn between 2022 and 2029.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9457

Key Manufacturers Continue to Strategize on New Product Launches in Electronic Stethoscopes Landscape

Almost 2/5th of total adoption of electronic stethoscopes is registered at hospitals, the report underscores that there has been significant adoption by medical institutes in the recent past. In the next few years, medical institutes and ambulatory surgical centers are likely to create multiple opportunities for manufacturers of electronic stethoscopes.

More than half of the overall sales is accounted by amplifying electronic stethoscopes, as indicated by FMI’s analysis. While amplifying electronic stethoscopes provide results as accurate as digitizing electronic stethoscopes, the latter are associated with high maintenance owing to the presence of multiple electronic components. Amplifying electronic stethoscopes are thus expected to observe significant growth in revenue over the course of coming years.

According to the report, the market attractiveness of amplifying stethoscopes is strongly backed by the increasing number of launches of new electronic stethoscopes by a number of small- and medium-sized companies. Electronic stethoscopes are rapidly replacing conventional variants across developed countries, predominantly owing to accelerated regulatory approvals.

  • eKuore had launched the first wireless stethoscope for medical use.
  • Eko had launched the first Android–connected digital stethoscope.
  • In April 2018, Steth IO launched a digital smartphone-enabled stethoscope.

According to the report, approximately 60% of the electronic stethoscopes that are sold are enabled with Bluetooth technology and an integrated chest piece system. The former is however poised to witness a higher rate of adoption over the coming years.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9457

North America Continues to Lead the Global Market for Electronic Stethoscopes

North America holds a considerable revenue share in the electronic stethoscopes market. With advancements in technology and the presence of a large number of healthcare facilities, electronic stethoscopes are being widely used in the region. Their ability to provide amplified sound output as well as reduce external sound makes it easy for medical professionals to detect sounds and provide proper treatment to patients.

FMI’s study has profiled some of the key companies operating in the global electronic stethoscopes market, including Eko Devices, eKuore, GlobalMed, 3M, Welch Allyn, Ambisea Technology Corp., Meditech Equipment Co., Ltd, HD Medical, Thinklabs, ADInstruments, and Cardionics Inc.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-9457

Electronic Stethoscope Market by Category

Product:

  • Amplifying Stethoscopes
  • Digitizing Stethoscopes

End User:

  • Hospitals
  • Clinics
  • Medical Institutes
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Medical Camps
  • Catheterization Laboratories

Application:

  • Integrated Chest-Piece System
  • Wireless Transmission System (Bluetooth)
  • Integrated Receiver Head-Piece System
  • Other

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Specialty Food Ingredients Market Size Analysis With Concentrate On Key Drivers, Trends & Challenges 2021-2022

The massive rise in demand for convenience foods from across the globe, mounting population in urban settings, and rising purchasing power of the global population are collectively driving the global demand for specialty food ingredients, observes a recent market research report published by Future Market Insights. The report is titled “Specialty Food Ingredients Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022).” The report states that the market will expand at a steady pace over the period between 2017 and 2022, rising to a revenue opportunity of nearly US$85,000 mn by the end of 2022.

Besides providing benefits in the form of extended shelf-life of a number of processed food products, specialty food ingredients also enhance qualities such as taste, texture, and flavor. Moreover, their addition to food products help reduce downstream losses owing to their impact on storage and processing of foods. These factors, along with the advent of several innovative technologies, such as the technology for decaffeination of coffee beans, has also increased the popularity of the global specialty food ingredients market.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4800

The report segments the global specialty food ingredients market on the basis of criteria such as specialty sensory ingredient, specialty fundamental ingredient, application, and geography.

In terms of specialty sensory ingredient, the market has been segmented into varieties such as emulsifiers, enzymes, colorants, and flavors. Of these, the segment of enzymes is likely to remain the most promising segment over the report’s forecast period, surpassing a revenue valuation of US$20,000 mn by 2022. Demand for colorants and emulsifiers is expected to see close competition in terms of revenue contribution to the global market throughout the report’s forecast period. The segment of flavors will exhibit expansion at the most promising pace over the report’s forecast period.

In terms of specialty functional ingredient, the report segments the market into vitamins, antioxidants, minerals, and preservatives. Of these, the segment of preservatives is expected to record a highly promising growth pace over the report’s forecast period. However, the segment of minerals, which is presently the most consumed functional ingredient in the global market, will continue to exhibit a promising pace of expansion over the report’s forecast period as well. The sales of vitamins could dwindle and the segment is expected to record the lowest CAGR of all the other segments over the forecast period.

The key application areas of specialty food ingredients examined in the report include beverages, bakery and confectioneries, dairy and frozen foods, functional foods, beverages and dietary supplements, meat products, oils and fats, and sauces, savory snacks, and dressings and condiments. Of these, the segment of bakery and confectionaries is expected to retain its position as the largest shareholder in the global market, followed by the segment of convenience foods. However, the demand from the meat products and functional food, beverages and dietary supplements segments will record a higher pace of expansion over the report’s forecast period.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4800

From a geographical standpoint, the market for specialty food ingredients in North America is slated to emerge as the one with the most lucrative growth opportunities over the report’s forecast period. The North America market for specialty food products is expected to rise to a valuation of nearly US$24,000 mn by the end of 2022.

Some of the leading players operating in the global specialty food ingredients market are E. I. Dupont De Nemours and Company, Advanced Food Systems Inc., Cargill Inc., Ingredion Incorporated, Specialty Commodities, Kerry Group Plc., Koninklijke DSM N.V., Sensient Technologies Corporation, Cambrian Solutions Inc., and Tate & Lyle.

 

Rosemary Extract Market By Glorious Opportunities, Business Growth, Size, And Statistics Forecasts Up To 2027

With differentiating strategies such as understanding the needs of customers, the global rosemary extract market products are gaining traction among consumers during the projected period, i.e. 2017 to 2027. “Rosemary Extract Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017–2027),” is the newly published report by Future Market Insights which offers insights on the global rosemary extract market. The market is likely to reach to US$ 1,063.2 Mn by 2027 end, expanding at the CAGR of 4.8 % during the assessed period of 10 years.

Following Factors to Contribute to the Growth of the Global Rosemary Extract Market

  • Increasing consumer inclination towards aromatherapy and preservatives boost the global rosemary market
  • Trending demand of herbal extract in European nutraceutical market contribute in the development in the global rosemary market
  • Growing personal care industry and increasing consumer awareness for rosemary
  • Growing demand for rosemary for pet food
  • Most importantly essential oil made of herb like rosemary and other spice extracts are used in cancer therapy that drives the global rosemary extract market
  • Advanced commercialization of herbs and spices by government create positive impact on the global rosemary extract market

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1579

Global Rosemary Extract Market- Forecast by Form

Based on form, the segment is divided into powder, liquid and others. The powder form is expected to account for the largest share owing to its longer shelf life. By 2027 end, powder segment is expected to account for 48.6% value share, and to be valued at US$ 516.3 Mn by the end of 2027. On the other hand liquid segment is expected to account for 46.7% market share, and to be valued at US$ 496.9 Mn by 2027 end.

Global Rosemary Extract Market- Forecast by Sales Channel

Based on sales channel, the segment is fragmented into two categories, i.e. direct sales and indirect sales. Direct sales to account for the largest share as the ingredient is used by the manufacturers for further processing such as personal care products, beverages, food and many more. Direct Sales segment is expected to remain dominant in the global rosemary extract market throughout the forecast period with a revenue share of 54.7 % by 2027. By 2027 end, indirect sales is expected to account for 45.3% value share, and to be valued at US$ 481.9 Mn.

Global Rosemary Extract Market- Forecast by Application

Application segment include food and beverages, personal care, nutraceutical, pharmaceutical and others. Pharmaceuticals and personal care are two major segments and the market witnesses an exponential growth for these segments over the forecast period. By 2027 end, personal care segment is expected to account for 25.9% value share, and to be valued at US$ 275.3 Mn.

Global Rosemary Extract Market- Forecast by Region

North America and APEJ are estimated to emerge as the most lucrative markets over the forecast period 2016-2027. The U.S. has already started the agricultural cultivation of Rosemary in the Southwest region. With easy trade flows and investment opportunities APEJ region represents potential segment for the growth of the market. Mediterranean countries, including Turkey, Spain, and Morocco are rapidly growing, expected to become commercial production hubs for Rosemary extracts in the global market.Europe is the supply base, led by Spain and France in terms of supply and export, and production and consumption respectively.

To gain more insights into the market with a detailed table of content and figures, click here:  https://www.futuremarketinsights.com/toc/rep-gb-1579

Global Rosemary Extract Market- Key Companies

The key players operating in the global rosemary extract market are- Givaudan SA, Kerry Group Plc., Takasago International Corporation, Dohler GmbH Sensient Technologies Corporation, Archer Daniels Midland Company, Ajinomoto Co., Inc., Symrise AG, Firmenich S A, Naturex SA, Kalsec Inc., Olam International, Foodchem International Corporation, McCormick and Company, Inc, Frutarom Industries Ltd., Robertet SA, Synthite Industries Ltd., International Taste Solutions Ltd, Organic Herb Inc., British Pepper and spice Company.

 

Baby Food Market Research Report – Opportunities & Challenges With Totally Different Segments, Forecast-2022

Future Market Insights (FMI) has published a new report, which is titled, “Baby Food Market: Infant Formula Sales to Record Rapid Growth: Global Industry Analysis (2012-2016) & Opportunity Assessment (2017-2022), Foods for babies that have nutritional values are very valuable for parents who are constantly on the lookout for new infant formulas and other baby foods that can be digested easily. Baby foods are one of the top most growing retail products in the industry of foods and beverages. Demand for baby foods or foods for babies continue to exist due to the continuous rise in the expenses of middle class parents in the world. Urban living along with lifestyle trends have resulted in the existence of working women, who are also mothers. Hence, baby foods are best alternatives to breast milk, and also supply essential nutrition to the babies.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4777

A newborn baby is of utmost importance to the parents, hence baby foods happen to be the most important thing in their shopping list. Baby food is soft and easy to consume item that is made as an alternative for breast milk, along with the basic nutrition in the required quantities resulting in healthy growth of babies. In the present scenario, baby foods are present in dried form, prepared form and also in the form of infant formulas.

The global market for baby foods is expected to be around US$62 bn by 2022, exhibiting a modest CAGR from 2017 to 2022. Reasons like growing trend of working mothers, the growing awareness of the advantages of foods for babies that are organic, and the increase in the number of births in various regions will drive the need for baby foods during next 5 years.

The report shows that the requirements for baby foods will lead the global market in the entire in the whole of the forecast period, although, the sales of infant formulas in the global market is predicted to be faster and higher in comparison to other baby foods market. Towards the end of 2022, infant formulas sales throughout the globe are expected to be more than 6% CAGR. In this forecast period, revenues earned through the dried baby food segment will have the least CAGR.  The segment for infant formulas will lead on account of increased usage of these products. Over one third of the revenue contribution of the global baby foods market will be through prepared baby foods segment, states the report.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4777

Companies involved in the making of baby foods, continuously face fierce competition in regards to the development of new baby foods along with stringent safety measures. As it is of utmost importance that baby foods be such that they have no element which will cause any health issues to babies, it becomes the responsibility of manufacturers to ensure that the ingredients used are safe yet nutritious. The products need to be developed keeping the sensitive and tender nature of babies as their digestive systems are not developed. This makes the task of manufacturing food for babies a complicated one. Players are strategically tapping into the high demand for organic food items which has struck the world and developing baby foods that are organic, in order to gain market shares.

The report profiles leading players such as Mead Johnson & Company, LLC, The Kraft Heinz Company, Campbell soups Company Nestlé S.A., Cargill Inc., Abbott Laboratories, The Hain Celestial Group, Inc., Hero Group A.G., DSM, Arla Foods amba, Danone, Bellamy Organics, and Perrigo Company.

 

Fortified Foods Market (Covid-19) Effect: Trends Together With Growth Forecast To 2031

Approximately 2 billion people across the world still lack access to the essential minerals and vitamins needed for a healthy and sustainable lifestyle. That is why food fortification programmes are actively encouraged by national governments, especially in developing nations. Future Market Insights has prepared an insightful report on the global fortified foods market titled ‘Fortified Foods Market: Global Industry Analysis 2017-2021 and Opportunity Assessment 2022-2032’. The fortified foods market is expected to push past US$ 500 Bn by the end of the forecast period witnessing a CAGR of 6.3% in terms of value during the forecast period.

Raw Material – Flour Most Important Raw Material in the Fortified Foods Market

The flour segment is anticipated to cross US$ 68 Bn by the end of 2032, registering a CAGR of 6.6%.

Micronutrients – Vitamins and Minerals to Record Robust CAGR Growth

Vitamins and minerals have a market share of more than 4/5th of the fortified foods market by micronutrients and are predicted to hold slightly increased share by the end of 2032. CAGR exhibited by minerals (6.5%) is higher than that of vitamins (6.4%) from 2022-2032 and the most important deficiency to address would be that of iron that is typically found in pregnant women and preschool children.

Get | Download Sample Copy with Graphs & List of Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-941

Application – Close Contest between Basic Foods and Processed Foods

The basic foods segment is just a little larger than processed foods in the fortified foods market and is likely to remain so for the foreseeable future. An absolute dollar opportunity of more than US$ 46 Bn exists in this market with margarine fortification being particularly important.

Technology – Drying and Extrusion Vital in the Fortified Foods Market

Key stakeholders in the fortified foods market would do well to focus on drying and extrusion technologies as they are vital. The drying technology is predicted to exceed US$ 87 Bn by end 2032. Extrusion though some way behind, is still critical in the fortified foods market and companies must not ignore it under any circumstance.

Sales Channel – Modern Trade and Neighbourhood Stores Lucrative Distribution Channels

The modern trade and neighbourhood stores segments are poised to grow by 190 and 17 BPS respectively and this is largely at the expense of online sales and other retail formats in the fortified foods market. Supermarkets and hypermarkets are preferred by customers for being ‘one-stop shops’.

Region – Maximum Growth in the Fortified Foods Market in the Dynamic APEJ Region

APEJ represents more than a third of the global fortified foods market and is projected to grow by a massive 214 BPS throughout the duration of the study. A number of public private partnerships in this region coupled with salt fortified with both iodine and iron has propelled the growth of the fortified foods market in APEJ.

Competition Landscape in the Fortified Foods Market

Future Market Insights has profiled some of the most prominent companies’ active in the fortified foods market. These include Nestlé S.A., BASF SE, General Mills, Tata Chemicals Limited, Mondelēz International, Cargill Incorporated, Danone, Bühler AG, Bunge Limited, Unilever PLC, Koninklijke DSM NV, Stern-Wywiol Gruppe GmbH & Co. KG, Arla Foods amba, Nutritional Holdings (Pty) Limited, Dr. Paul Lohmann GmbH KG Chemische Fabrik, Wright Enrichment Inc., Gastaldi Hermanos, Sinokrot Global, Ufuk Kimya Ilac Sanayi Ve Ticaret Limited Sirketi, and Corbion NV.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-941

Important Takeaways from the Fortified Foods Market Report

Nutritional deficiencies are more common in emerging economies. To strengthen their food fortification structures, developed countries are collaborating with governments in emerging economies by assisting in the setup of manufacturing units, providing technological support, and financial aid. While China could potentially slow down, Brazil and India are on track to record significant growth in the fortified foods market.

 

Skin Antiseptic Market Growth Factors, Applications, Regional Analysis, Key Players And Forecasts By 2031

According to the latest research by Future Market Insights, the skin antiseptic market is set to witness rapid growth during the forecast period (2021-2031). Demand for skin antiseptic witnessed rapid recovery in the short term, with an optimistic growth outlook in the long run. High demand for skin antiseptic expects to offer lucrative opportunities in near future, however, sales of skin antiseptic to treat the prevalence of infection will drive the market growth.

What are the Factors Likely to Drive the Skin Antiseptic Demand?

Due to the potential for contamination with pathogenic organisms and the increased likelihood of selecting potential and effective treatment for resistant organisms has surged demand for skin antiseptics that expects to drive the skin antiseptic market growth in coming years.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13196

Sales of solution-based skin antiseptics are expected to offer lucrative opportunities for the European skin antiseptic market. Due to the growing prevalence of Surgical Site Infections (SSIs) and Healthcare-associated infections (HAIs) and the easy availability of various antiseptic solutions accounted for the highest revenue-generating category. Growing R&D and focus on efficacy improvement and growing applications of antiseptic solutions are expected to propel the segment further in the pre-operation and pre-injection procedures.

In addition based on the surgeries applications, the adoption of skin antiseptics is growing in the healthcare sector. Especially to reduce the risk of infection.

Chlorhexidine Gluconate Ingredient is Likely to Influence the Skin Antiseptic Sales

Chlorhexidine gluconate have been the dominating the global skin antiseptic market. According to a study published in Massachusetts Medical Society, concluded that chlorhexidine–alcohol has superior clinical efficacy and is more effective than povidine iodine-containing solutions in reducing the bacterial concentration in the operative field for vaginal hysterectomy.

US and Canada Skin Antiseptic Market Outlook

US is one of the largest markets for skin antiseptic globally. The US skin antiseptic market is set to tread on the historic pattern of bust and boom during the assessment period 2021-2031.

Demand for skin antiseptic in US and Canada will be led by negatively affecting the market growth by the increase with the rate of surgeries being performed. Pre-operative skin assessment is the initial step planned by the surgeon before the surgeries. Injection by application segment expects to project a steady growth in coming years. According to Consumer Healthcare Products estimation in US the OTC sales would reached between 36 and 37 billion U.S. dollars by 2020.

Europe Demand Outlook for Skin Antiseptic

Many countries in EU have severely been impacted by the COVID-19 crisis, which has led to a drop in economic activities. However, as is the case in US and Canada, pharmaceutical spending in EU continues to drive skin antiseptic demand.

In Europe, uncertainties in the wake of Brexit persist, especially concerning potential supply-chain disruptions, depending on how well the second phase of exit negotiations turns out. The UK pharmaceutical sector receives about 70% of imports from Europe. According to OECD data, around four out of every five euros are spent on retail pharmaceuticals goes on prescription medicines, while the rest on OTC medicines. The share of OTC medicines is particularly high in European countries such as Poland, accounting for half of the pharmaceutical spending, and stands for around 30% or more in Spain (36%), Cyprus (30%) and Latvia (31%) in 2018.

Who are the Key Manufacturers and Suppliers of Skin Antiseptic?

Some of the leading manufacturers and suppliers of skin antiseptic market include

  • 3M Company
  • BD
  • Johnson & Johnson Services, Inc.
  • Reckitt Benckiser
  • B. Braun Melsungen AG
  • Purdue Pharma L.P.
  • EcoLab
  • Schülke & Mayr GmbH
  • PSK Pharma Pvt. Ltd.
  • Kimberly-Clark
  • Sirmaxo Chemicals Pvt. Ltd.
  • Avrio Health L.P.
  • Others

Growth strategies adopted by the leading pharmaceutical companies have influenced the market. The growing contribution by the key players as well as the governments to educate and spread awareness of antiseptic skin products are likely to boost the growth of the antiseptic skin industry substantially.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Skin Antiseptic Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13196

Key Segments of Skin Antiseptic Market

By Ingredient Type:

  • Alcohol
    • Isopropyl alcohol 70%
    • Ethyl alcohol 70%
  • Chlorhexidine and other diguanide
    • Chlorhexidine acetate
    • Chlorhexidine gluconate
  • Quaternary ammonium compound
    • Benzalkonium chloride
    • Cetrimide
    • Methylbenzethonium chloride
    • Benzethonium chloride
    • Cetalkonium chloride
    • Cetylpyridinium chloride
    • Others
  • Halogenated phenol derivative
    • Chlorocresol
    • Chloroxylenol
    • Chlorophene
    • Other
  • Antibacterial dye
    • Triphenylmethane
    • Proflavine hemisulphate
    • Brilliant green
    • Gentian violet
    • Crystal violet
  • Peroxide and permanganate
    • Potassium permanganate solution
    • Hydrogen peroxide solution
    • Benzoyl peroxide
  • Quinolone derivative
    • Hydroxyquinoline sulphate
    • Chlorquinaldol
    • Potassium hydroxyquinoline sulphate
    • Dequalinium chloride
    • Diiodohydroxyquinoline
  • Miscellaneous
    • Burow’s solution (aqueous solution of aluminium acetate)
    • Bleach baths

By Form:

  • Solutions
  • Cream
  • Spray
  • Soaps
  • Swab Sticks
  • Wipes

By Type:

  • Oral
  • Topical

By Application:

  • Wounds
  • Surgeries

By Distribution Channel:

  • Supermarket/ Hypermarket
  • Drug Stores
  • Retail Pharmacies
  • E-commerce

 

Pain Patches Market In-Depth Overview, Growth Factors, Regional Analysis And Forecasts Outlook-2031

According to latest research by Future Market Insights, pain patches market will experience substantial growth during the forecast period 2021-2031. Demand for pain patches will elevate in the course of forecast period while experiencing a steady growth. Increased demand pain patches to encounter the pain resulted from various medical conditions represents lucrative growth for pain patches market.

What is Driving Demand for Pain Patches?

Pain patch is a medicated adhesive patch that is used to relieve the pain by placing it on the skin. Pain patch uses a transdermal route and therefore provides an advantage of controlled delivery of medication as compared to other routes of administration. This advantage may result in increasing the sales of pain patches during the forecast period.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13194

Increasing number of accidents that result in severe injury is expected to drive the growth of pain patches market across the globe. According to the Association for Safe International Travel, in 2020, approximately 4.4. million individuals were severely injured to require medical attention in the U.S. Moreover, increasing number of sports related injuries will also lead to a rise in demand for pain patch market.

In addition, changes in lifestyle and emergence of more office related jobs that needs continuous sitting in one position for too long may result in back related ailments among others. This will also lead to significant growth in the pain patches market.

Increasing Prevalence of Arthritis Expected to Augment the Growth of Pain Patches Market

Increasing chronic and acute pain related diseases is expected to reflect a positive growth for pain patches market. One such disease is arthritis which results in severe joint pain. The increasing prevalence of arthritis mainly is expected to increase the demand for pain patches. According to CDC, in 2018, an estimated 22.7% of the U.S. population of adults had doctor diagnosed arthritis.

U.S. and Canada Pain Patches Market Outlook

U.S. and Canada are among the largest market for pain patches market making North America a dominant player. The adoption of transdermal pain patches has increased in North America for pain management of certain conditions, which includes cancer. Pain patches are quite effective as compared to pain killers as they deliver pain management drugs at a predetermined rate across the dermis and achieve a local or a systemic effect.

This indicates that high prevalence of cancer will lead to rise in demand for pain patches market. According to National Cancer Institute, in 2018 an estimated 16,353,421 people living with cancer of any site in the U.S.

Europe Demand Outlook for Pain Patches

Increasing usage of pain patches for pain management for non-cancer conditions is expected to drive the growth of the pain patches market in this regions. Additionally, the increasing research and development funding and increasing focus of the European governments on the healthcare system also represents steady growth for pain patches market.

Moreover, favourable reimbursement policies in many European countries will also boost further growth of the pain patches market.

Who are the Key Manufacturers and Suppliers of Pain Patches?

Some of the leading manufacturers operating in the pain patches market include

  • Viatris, Inc.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Hisamitsu Pharmaceutical Co., Inc.
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Nichiban Co., Ltd.
  • Teikoku Seiyaku Co, Ltd.
  • Mentholatum Company.

Many leading manufacturers in the pain patches market are focusing on getting FDA approvals for their products. For instance, in July 2020, the FDA approved an 8% capsaicin pain patch for diabetic neuropathy. Manufacturers in the market are also focused carrying out acquisitions that will broaden their product portfolio. In July 2019, GlaxoSmithKline acquired the Pfizer’s Consumer Health Business which includes OTC products for topical pain management.

The Report Covers Exhaustive Analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2016 – 2020
  • Market Size & Forecast 2021 to 2031
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional Analysis Includes:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-13194

Key Segments of Pain Patches Market

By Product Type:

  • Opioid Patches
    • Buprenorphine
    • Fentanyl
  • Non-opioid Patches
    • Diclofenac patches
    • Lidocaine patches
    • Ketoprofen patches
    • Capsaicin patches
    • Methyl Salicylate Patches

By Therapeutic Application:

  • Pain relief
  • Cough Suppression
  • Anesthesia
  • Diarrhea Suppression
  • Smoking Cessation

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

 

Hearing Amplifiers Market – Outlook On Emerging Application, Revolutionary Trends & Potential Growth Strategies 2031

According to the latest research by Future Market Insights, the Hearing amplifiers market is set to witness steady growth during 2021-2031. The rising prevalence of hearing impairment disorder, coupled with the growing geriatric population prone to hearing loss is increasing the demand for hearing amplifiers.

What Is Driving The Demand For The Hearing Amplifiers Market?

To meet the end-users demand for advanced, safe and cost-effective alternative to hearing aids devices continues to drive demand for hearing amplifiers in the market. Similarly, the increasing cost of hearing aids is creating huge opportunities for hearing amplifiers manufacturer to develop an advanced, cost-effective solution to solve the unmet demand of consumers.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13191

Growing Geriatric Population Is Likely To Accelerate The Demand for Hearing Amplifiers.

The growing geriatric population is a significant driving factor for the growth of the hearing amplifiers’ market. The geriatric population are more prone to hearing loss when compared with children. As per the world health organization (WHO), currently, about 466 million people have hearing problems across the globe and the number is projected to reach 900 million by 2050.  Among these, only 34 million are children. This number indicates growing geriatric population creates huge opportunities in the hearing amplifiers market.

The U.S. and Canada Hearing Amplifiers Market Outlook

The U.S. is one of the largest markets for hearing amplifiers globally. The U.S. Hearing amplifiers market is set to tread on the historic pattern of bust and boom during the assessment period 2021-2031.

Favorable healthcare policies, coupled with high per capita healthcare spending, has created a conducive environment for the adoption of hearing amplifier devices in the U.S. presence of leading players in the region is also expected to boost the market growth. Most of the key players are focusing on strategic acquisitions to strengthen their product portfolio.

For instance, in 2021, Amplifon S.p.A. acquired PJC Hearing, the hearing care business of PJC Investments LLC, which is the second-largest Miracle-Ear franchisee in the United States, which covers the major market in hearing care worldwide.

Europe Demand Outlook for Hearing Amplifiers Market

The rising prevalence of deafness, increasing awareness and the introduction of technologically advanced products are expected to contribute to the market growth of hearing amplifiers in Europe. Furthermore, favorable reimbursement policies accepted by each region of Europe is driving the growth of the market. Anteunis (1999) estimated that up to 52 million Europeans (20% of adults) and 36% of the older population suffer from some level of hearing handicap. According to the British MRC Institute of Hearing Research study, around 900 million people across the globe will suffer from hearing loss by 2025. Among this population, more than 90 million patients may be from Europe.

Who are the Key Manufacturers and Suppliers of Hearing amplifiers?

Some of the leading manufacturers and suppliers of hearing amplifiers include

  • iHEAR Medical, Inc.
  • Soundhawk
  • FocusEar
  • Resound
  • Shenzhen LA Lighting Company Limited
  • Foshan Vohom Technology Co. Ltd.
  • MDHearingAid
  • Beurer
  • Etymotic Research
  • IntriCon Corporation
  • Britzgo
  • Austar Hearing Science and Technology (Xiamen) Co., Ltd.
  • Sound World Solutions
  • Huizhou Jinghao Electronics Co. Ltd.
  • Otofonix
  • Banglijian
  • Amplifon
  • Ziphearing
  • Others

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Hearing Amplifiers Market Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13191

Key Segments of Hearing Amplifiers Market

By Product Type:

  • On the ear
  • In the ear
  • In-the-canal
  • Behind-the-ear (BTE)
  • Mini BTE

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • The U.K.
    • Germany
    • France
    • Spain
    • Russia
    • Benelux
    • Rest of Latin America
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia
    • India
    • ASEAN
    • Rest of South Asia
  • Oceania
    • Australia
    • New Zealand
  • The Middle East and Africa
    • GCC Countries
    • North Africa
    • South Africa
    • Turkey
    • Rest of the Middle East

 

Research Antibodies Market Size, Share, Future Road-map, Technological Innovations & Growth Forecast To 2031

According to the latest research by Future Market Insights, the research antibodies market will experience substantial growth during the forecast period 2021-2031. Demand for research antibodies will elevate in the course of the forecast period while experiencing steady growth. Increased demand for research antibodies in diagnostic purpose and determination of serious medical conditions represents lucrative growth for the research antibodies market.

What is Driving Demand for Research Antibodies?

Research specific antibodies are something where protein is used externally to detect the unwanted molecule into the body. It is basically used to understand what is going wrong in a cell or body. It acts as a biomarker to detect life-threatening diseases.

Increasing prevalence of chronic diseases and outbreak of infectious disease is expected to drive the growth of research antibodies market across the globe. According to World Health Organization, in 2020, approximately 1.5. Mn individuals were severely affected by an infectious disease like the coronavirus who require medical attention. Moreover, an increasing number of chronic disease patient like cancer, immunological disorders, etc. will also lead to a rise in demand for the research antibodies market.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13189

In addition, tremendous research in the field of chronic disease and its diagnosis mitigation and treatment. This will also lead to significant growth in the research antibodies market.

Increasing Prevalence of Chronic Disease may Grow Research Antibodies Market

Increasing prevalence of the chronic disease is expected to reflect positive growth for the Research Antibodies market. One such disease is cancer which results in severe life threatening condition. The increasing prevalence of cancer mainly is expected to increase the demand for Research Antibodies. According to National Cancer Institute, in 2018 an estimated 16,353,421 people living with cancer of any site in the U.S.

U.S. and Canada Research Antibodies Market Outlook

U.S. and Canada are among the largest market for research antibodies market making North America dominant. The U.S is growing due to high investments for the development of structure-based drug designs model, growing research in the fields of primary and secondary antibodies, and the focus of stakeholders on research projects involving proteins associated antibodies, research on biomolecules, and genes are the key driving factors of the market in U.S and Canada.

Europe Demand Outlook for Research Antibodies

Increasing usage of research antibodies for diagnostic and also in research work and clinical trials is expected to drive the growth of the research antibodies market in these regions. Additionally, the increasing research and development funding and increasing focus of the European governments on the healthcare system also represents steady growth for the research antibodies market.

Moreover, favourable reimbursement policies in many European countries will also boost further growth of the research antibodies market.

Who are the Key Manufacturers and Suppliers of Research Antibodies?

Some of the leading manufacturers operating in the research antibodies market include

  • Thermo Fisher Scientific
  • Merck Group
  • Abcam plc
  • Becton
  • Dickinson and Company
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Agilent Technologies
  • PerkinElmer
  • Lonza
  • GenScript
  • BioLegend
  • Yashraj biotechnology Ltd.

Many leading manufacturers in the research antibodies market are focusing on getting FDA approvals for their products. For instance, In 2020, Thermo Fisher Scientific collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies. In 2020, Merck partnered with Elypta to provide contract manufacturing services for Elypta’s clinical diagnostic liquid biopsy kits.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2016 – 2020
  • Market Size & Forecast 2021 to 2031
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional analysis includes:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-13189

Key Segments of Research Antibodies Market

By Product Type:

  • Primary Antibodies
    • Cancer research
    • Stem cell research
    • Neurobiology research
    • Epigenetics research
    • Infectious disease research
    • Apoptosis research
  • Secondary Antibodies
    • Western Blotting
    • Flow Cytometry
    • ELISA
    • Immunohistochemistry
    • Immunofluorescence
    • Immunoprecipitation
    • Others
  • Immune Checkpoint Antibodies

By Antibodies Form:

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Others

By Source:

  • Mice
  • Rabbit
  • Others

By Application:

  • Drug Discovery & Development
  • Basic Research
  • Toxicity Screening
  • Biopharmaceutical Production
  • Drug Screening
  • Tissue Engineering
  • Forensic Testing

By End Users:

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Forensic Science Laboratories
  • Diagnostic Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa